Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Lishan Aklog
AddedMar 31, 2024
UpdatedMay 31, 2026
Lishan Aklog

Lishan Aklog

Board Member, Lucid Diagnostics

CrunchbaseLinkedIn

Lishan Aklog's Career

Lucid Diagnostics
Lucid Diagnostics

New York City, NY, US

Board Member· Board
Pavmed
Pavmed

New York City, NY, US

Board Member· Board
HealthChain
HealthChain

Scotch Plains, NJ, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Lishan Aklog's Career

Lucid Diagnostics
Lucid Diagnostics
Public$18.6M1292018New York City, NY, US
Board Member· Board

Leadership at Lucid Diagnostics

Amitabh ChakAmitabh ChakBoard Member
Joe WillisJoe WillisBoard Member
Shaun O'NeilShaun O'NeilCo-Founder
Dr. Sanford D. Markowitz M.D., Ph.D.Dr. Sanford D. Markowitz M.D., Ph.D.Co-Founder
Pavmed
Pavmed
Public$69M1242014New York City, NY, US
Board Member· Board

Leadership at Pavmed

Debbie WhiteDebbie WhiteBoard Member
Tim BaxterTim BaxterBoard Member
Brian DeguzmanBrian DeguzmanCo-Founder
Daniel EngelmanDaniel EngelmanBoard Member
Michael GlennonMichael GlennonBoard Member

Similar to Pavmed

Lucid DiagnosticsLucid DiagnosticsNew York City, NY, USMedical Devicesest. 2018Lucid DiagnosticsNew York City, NY, US · est. 2018

Lucid Diagnostics, a PAVmed subsidiary, pioneers in cancer-prevention diagnostics with breakthrough devices.

Public · $18.6M129
Pavad MedicalPavad MedicalFremont, CA, USMedical Devicesest. 2002Pavad MedicalFremont, CA, US · est. 2002

Pavad Medical Inc., a US-based startup, provides innovative healthcare services via medical devices.

Series C · $23.6M30
PromedixPromedixPortland, OR, USMedical Devicesest. 2019PromedixPortland, OR, US · est. 2019

Promedix: Innovating home patient monitoring with medical devices for trauma, dehydration, and sepsis care.

Angel · $350k5
HealthChain
HealthChain
Seed$48k302019Scotch Plains, NJ, US
Co-Founder

Similar to HealthChain

MintHealthMintHealthSan Diego, CA, USHealth Platformest. 2017MintHealthSan Diego, CA, US · est. 2017

MintHealth: A global, decentralized platform empowering patients through aligned healthcare.

Angel · $529k30
MedBloxMedBloxCoralville, IA, USData Exchange, Healthcareest. 2018MedBloxCoralville, IA, US · est. 2018

MedBlox: A decentralized healthcare tech provider empowering patients to own and exchange their records.

Pre-Seed · $250k9
healthblockhealthblockPalo Alto, CA, USApplications, Healthcareest. 2018healthblockPalo Alto, CA, US · est. 2018

Healthblock: Connecting providers and patients through digital health solutions.

Seed · $1.4M30
HealthInRealTimeHealthInRealTimeSan Francisco, CA, USDigital Health, Fitness Trackingest. 2022HealthInRealTimeSan Francisco, CA, US · est. 2022

HealthInRealTime: A blockchain-powered digital health platform offering real-time fitness monitoring, data protection, and health rewards.

Pre-Seed · $250k3

Lishan Aklog's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Lishan Aklog

Dennis M. McGrathDennis M. McGrathBoard Member · Gadsden PropertiesGrace ChenGrace ChenCo-Founder · LucidAct HealthOctavian FlorescuOctavian FlorescuFounder · In DiagnosticsMichael E. StewartMichael E. StewartBoard Member · Lucid HoldingsAlexander WalshAlexander WalshFounder · Envision DiagnosticsKen JordanKen JordanCo-Founder · Lucid News